Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Darifenacin (ATC-Code: G04BD10).
AOK Niedersachsen. Die Gesundheitskasse.
The work
Conclusion of a non-exclusive discount contract for Darifenacin (ATC-Code: G04BD10) via an 'open-house model' from 01.12.2025 to 30.11.2027.
- Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
- Contracts are non-exclusive and have uniform conditions.
- Submission of contract documents by 27.10.2025 for a 01.12.2025 start.
Key facts
- Contract period
- Up to 24 months, ending by 30.11.2027.
- Evaluation
- Not a public procurement tender; selection is based on meeting the legal definition of a pharmaceutical entrepreneur.
What it takes to qualify
Worth a closer look
- The tender is not a public procurement in the sense of Directive 2014/24/EU.
- The publication is in the Supplement to the Official Journal of the European Union.
- The procedure is termed 'offenes Verfahren' due to the publication form.
Experience
- At least 1 similar work — Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
- Being a pharmaceutical entrepreneur with a seat in the AMG area, EU, or EEA.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not stated in the provided text.
PAN registration (optional)Not stated in the provided text.
EPF registration (optional)Not stated in the provided text.
ESIC registration (optional)Not stated in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contract documents and conditionsTo be requested from AOK Niedersachsen and submitted for contract conclusion.